Amyloid 296 Subject

Human amylin, or islet amyloid polypeptide (hlAPP), is a 37-residue peptide hormone which forms both intracellular and extracellular (EC) amyloid deposits in the pancreas of most type II diabetic subjects. The core of the structure in the SDS micelle is an ot-helix that runs from about residues 5-28. Although the basic structural unit in the fibrils in... 

Compound B (PIB) which demonstrates AP amyloid burden in vivo. This brain penetrant nC-labeled uncharged thioflavin derivative binds to A[3 with high affinity [16]. The PET patterns of labeled PIB are interpreted to reflect the A[3 burden in the brain [ 16]. In comparison with controls, subjects with AD show marked retention of label in several areas of brain that usually accumulate amyloid. This approach should eventually prove useful for enhancing accuracy of diagnosis and should allow assessment of the efficacies of new anti-amyloid therapeutics. Further details of brain imaging are found in Ch. 58. 

Yamaguchi, H., SugUiara, S., Ogawa, A., Oshima, N., lhara, Y. (2001) Alzheimer beta amyloid deposition enhanced by APOE epsUon 4 gene precedes neurofibritlary pathology in the frontal association cortex of non-demented senior subjects. J. Neuropathol. Exp. Neurol, 60,731-739. 

Tokuda, T., Tamaoka, A., Matsuno, S., et al. (2001) Plasma levels of amyloid-beta proteins do not differ between subjects taking statins and those not taking statins. Arm. Neurol., 49, 546-547. 

Riemenschneider, M., Lautenschlager, N., Wagenpfeil, S., Diehl, J., Drzezga, A., et al. (2002) Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 59, 1729-1734. 

Fig. 14.6. De novo amyloid formation of prion protein at different concentrations. Different concentrations of unexposed prion protein (0.1, 0.25, 0.5, 0.75 and l.OmgmV1) and UV-exposed prion protein (l.Orngrnl ) were subjected to amyloid-forming conditions. The figure shows representative data at each concentration. Exposed represents UV-exposed prion protein...

Another mechanism proposed for the therapeutic effect of nicotine in Down syndrome is that the high levels of f) amyloid present in the Down syndrome brain are inhibiting the function of al nAChRs essentially as described above in Alzheimer s disease (Deutsch et al., 2003). However, a recent report found no correlation between f) amyloid levels and dementia in older Down syndrome subjects (Jones et al., 2009). Therefore, despite the therapeutic effect of nicotine in Down syndrome, the specific role of nAChRs remains elusive. 

Proteins are subject to selection pressure and adapt to become good folders, i.e., expeditious structure seekers with a reproducible and stable soluble structure. This optimization is needed to prevent the functionally competent fold from reverting to a primeval amyloid phase. On the other hand, certain sequences are better optimized to escape aggregation than others even under conditions known to sustain the native fold [8],... 

The biological activity, if any, of sAPPjS is so far unknovm. The role or contribution of N-truncated Aj3 (p3, for example) to AD is the subject of a hotly contested debate, entitled the shorter amyloid cascade hypothesis (87,105). 

---